Medacta Group Sa Stock Short Ratio

The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.

Based on the latest financial disclosure, Medacta Group SA has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The short ratio for all Switzerland stocks is 100.0% higher than that of the company.

The Macroaxis Fundamental Analysis modules help investors analyze Medacta Group SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medacta Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medacta Group SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.